Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lung Neoplasms 1

Interventions

Specimen Handling 191Magnetic Resonance Spectroscopy 141Biopsy 102pembrolizumab 85Carboplatin 79Cisplatin 71Nivolumab 64Paclitaxel 52Radiotherapy 51Gemcitabine 51Cyclophosphamide 48Dexamethasone 47durvalumab 39Radiation 39atezolizumab 38Pemetrexed 38olaparib 34Rituximab 34venetoclax 33Etoposide 33Lenalidomide 32Doxorubicin 32Bevacizumab 32X-Rays 30Prednisone 30Docetaxel 30Disulfides 28Ipilimumab 27Immunoglobulin G 27Fluorouracil 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Carbon Monoxide × 30 days × Clear all
NCT06038526 2026-05-20

Evaluation of Canakinumab in High-Risk Former-Smokers

Ohio State University Comprehensive Cancer Center

Phase 2 Active not recruiting
41 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡